• The Susan F. Smith Center for Women's Cancers at Dana-Farber unites many of the world's leading experts in breast and gynecologic cancers with one common goal: to give all women the latest, most advanced care, including innovative therapies that are often available only through clinical trials.

    The Susan F. Smith Center for Women's Cancers creates powerful possibilities by bridging compassionate care with world-class basic and clinical research. A place of hope and action, we offer a full spectrum of services that nourish body, mind, and spirit. From the moment a patient arrives for her first appointment to the day her treatment ends, we surround her with a circle of support.

  • The Susan F. Smith Center for Women's Cancers began as an idea to unite the clinical and research strengths of the breast and gynecologic cancer programs. This notion of a center dedicated to studying and treating all women's cancers captured Dana-Farber Trustee Susan F. Smith's imagination. Her determination to make the center a reality — along with the strong support of many other individuals and organizations — has been a steady force behind its growth.

    Today, we are pushing the frontier of research for women's cancers by developing innovative therapies and setting cancer care standards for other physicians across the country and around the world.

    Strengthening collaborations

    The Susan F. Smith Center was designed to increase opportunities for scientific collaboration. Physicians and scientists don’t have to travel far to meet: an enclosed bridge connects clinical care with corresponding research facilities in the Richard A. and Susan F. Smith Research Laboratories next door. The proximity promotes translational research that converts scientific advances into new treatments.

    The Susan F. Smith Center at Dana-Farber shares advances in cancer research and treatment with the healthcare community through continuing medical education courses.

    Learn more about continuing medical education.

    Accolades and awards

    Highlights of the work of the Susan F. Smith Center for Women's Cancers include:

    • A Specialized Program of Research Excellence (SPORE) led by Eric Winer, MD, is a prestigious five-year grant funded by the National Cancer Institute and includes projects aimed at identifying drug "targets" on breast cancer cells.
    • An Ovarian Cancer Dream Team is studying therapies involved in DNA repair. Experts on the team, which includes Ursula Matulonis, MD, will build on recent clinical advances seen with the drug olaparib and other PARP inhibitors in current clinical trials.
    • Myles Brown, MD, received the Susan G. Komen® Brinker Award for Scientific Distinction in Basic Science. Established in 1992, the award recognizes the efforts of pioneers in two critically important areas of the fight to end breast cancer: clinical research and basic science.
    • The Susan F. Smith Center presented its annual course on controversies and new horizons in breast cancer. The educational event, now led by Harold Burstein, MD, PhD, attracts hundreds of breast cancer clinicians from around the world.